Examples of using Induction therapy in English and their translations into Romanian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
reduce the content of abnormal cells in the body(induction therapy);
465 patients with relapsed/ refractory follicular NHL were randomised in a first step to induction therapy with either CHOP(cyclophosphamide, doxorubicin,
All subjects received open-label induction therapy at a dose based on their Baseline body weight: 160 mg at Week 0 and 80 mg at
465 patients with relapsed/refractory follicular lymphoma were randomised in a first step to induction therapy with either CHOP(cyclophosphamide, doxorubicin,
triple combinations with other chemotherapeutic agents, as induction therapy prior to stem cell transplantation in patients with previously untreated multiple myeloma.
Its main goal is to get the disease under control as soon as possible(induction therapy) and to maintain the control long-term(maintenance therapy),
triple combinations with other chemotherapeutic agents, as induction therapy prior to stem cell transplantation in patients with previously untreated multiple myeloma.
phase III trial 1193 patients with previously untreated advanced follicular lymphoma received induction therapy with R-CHOP(n=881), R-CVP(n=268)
A higher risk of thrombosis during induction therapy with asparaginase and prednisone was seen in children with a genetic prothrombotic risk factor(factor V G1691A-mutations,
including amphotericin B) had asymptomatic torsade de pointes during induction therapy for relapsed APL with arsenic trioxide.
A total of 334 patients achieving a complete or partial remission following induction therapy were randomised in a second step to MabThera maintenance therapy(n=167) or observation(n=167).
2 or>= 3), induction therapy(R-CHOP, R-CVP or R-FCM) and regardless of the quality of response to induction treatment(CR,
2 or>= 3), induction therapy(R-CHOP, R-CVP or R-FCM)
As induction therapy, interferon alfa-2b is administered intravenously at a dose of 20 million IU/m2 daily for five days a week for a four-week period;
in combination with intensive chemotherapy after induction therapy.
in combination with intensive chemotherapy after induction therapy.
After completing induction therapy, patients were randomized to receive either Zevalin(250 mg/ m2 rituximab on day -7
in combination with intensive chemotherapy after induction therapy. imatinib was administered intermittently in cohorts.
Induction therapies included CVP n=106, CHOP(-like) n=188,